SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-07-000081
Filing Date
2007-10-19
Accepted
2007-10-19 15:30:37
Documents
2
Period of Report
2007-10-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FDA PDUFA LETTER 10-18-07 fdapdufaletter.htm 8-K 17409
2 PRESS RELEASE PDUFA LETTER 10-18-07 pressreleasepdufaletter.htm EX-99.1 24549
  Complete submission text file 0000812796-07-000081.txt   43650
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 071181092
SIC: 2834 Pharmaceutical Preparations